- Report
- March 2024
Australia
From €1838EUR$1,850USD£1,528GBP
- Report
- March 2024
India
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2024
Saudi Arabia
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2024
China
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2024
South Korea
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2024
Australia
From €1490EUR$1,500USD£1,239GBP
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2024
Germany
From €3477EUR$3,500USD£2,891GBP
- Report
- March 2024
United Kingdom
From €3477EUR$3,500USD£2,891GBP
- Report
- March 2024
France
From €3477EUR$3,500USD£2,891GBP
- Report
- November 2023
- 290 Pages
China
From €3974EUR$4,000USD£3,304GBP
- Report
- July 2023
- 172 Pages
Global
From €3800EUR$3,825USD£3,160GBP
€4471EUR$4,500USD£3,717GBP
- Report
- October 2018
- 106 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €348EUR$350USD£289GBP
€497EUR$500USD£413GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €348EUR$350USD£289GBP
€497EUR$500USD£413GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €348EUR$350USD£289GBP
€497EUR$500USD£413GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €348EUR$350USD£289GBP
€497EUR$500USD£413GBP
- Report
- October 2024
- 93 Pages
Global
From €3500EUR$3,774USD£3,012GBP
- Report
- October 2024
- 111 Pages
Global
From €3500EUR$3,774USD£3,012GBP
- Report
- October 2024
- 88 Pages
Global
From €3500EUR$3,774USD£3,012GBP
The Hematological Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat hematological diseases. These diseases include anemia, leukemia, lymphoma, and other blood disorders. Hematological drugs are used to treat a variety of conditions, including cancer, autoimmune diseases, and blood disorders.
The hematological drugs market is composed of a variety of companies, including large pharmaceutical companies, biotechnology companies, and specialty drug companies. These companies develop and produce drugs to treat hematological diseases, as well as other conditions. Some of the major players in the hematological drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more